Supports the link: most studies of acetaminophen in pregnancy report a higher risk of autism or ADHD, a 2025 review found the better studies more likely to show it, and the FDA moved to warn on the label. Avoiding unneeded use is a sensible precaution.
A 2025 review of 46 studies in Environmental Health found 27 reporting positive associations with neurodevelopmental disorders and said higher-quality studies were more likely to show them. In September 2025 the FDA began a label change, citing a considerable body of evidence of potential risk, especially with chronic use. Because most low-grade fevers need no treatment, limiting unnecessary use costs little.The case for a link comes from the accumulated observational literature. A 2025 review in Environmental Health, using the Navigation Guide method, identified 46 studies: 27 reported positive associations with autism, ADHD or other neurodevelopmental disorders, 9 were null and 4 suggested protective effects. The authors reported that higher-quality studies were more likely to show positive associations and called for "appropriate and immediate steps" to advise pregnant women to limit use (Prada et al., 2025).
Regulators acted on that body of work. In September 2025 the FDA began the process of changing acetaminophen's label, citing "a considerable body of evidence about potential risks," and noted that some studies describe the risk as most pronounced with chronic use throughout pregnancy (FDA). The agency's own reasoning supports caution even without proof: most low-grade fevers do not need treatment, so avoiding unnecessary or prolonged use has little downside.
Sibling comparisons, the main counter-evidence, are not decisive either. They rely on pairs of siblings with different exposure, who may differ in other ways, and on how exposure was recorded.
Limits. Association is not causation, and the FDA itself said "a causal relationship has not been established." One senior author of the 2025 review disclosed serving as a plaintiffs' expert witness in acetaminophen litigation. Large sibling-controlled studies and a 2026 meta-analysis have since found no link, and untreated high fever in pregnancy carries its own risks.